Morgan Stanley (NYSE:MS) initiated coverage on Novartis (SIX:NOVN:SW) (NYSE: NVS) with an Underweight rating and set a price ...

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.

In the Australian health and biotechnology sector it can be common for leaders to be involved in multiple companies and ...

Teva Pharmaceutical Industries Ltd. ADR-1.25% $19.09B ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Spotify Technology S.A.-2.28% $128.04B ...

Leverage these to understand future stock performance and identify high performing investment ideas. You can also filter these to get relevant data aligned with your investing style and specific ...

Nearly 30% of midcap & small-cap stocks are at/near 52-week lows 99% of midcap & 95% of small-cap 100 stocks close with cuts today ...